Results 251 to 260 of about 162,217 (316)

Longitudinal genome‐wide aneuploidy measurements in circulating cell‐free DNA to predict lack of benefit from pembrolizumab in patients with metastatic urothelial cancer

Molecular Oncology, EarlyView.
Many patients with urothelial cancer do not benefit from treatment with pembrolizumab, while at risk of severe side effects. Changes in the levels of circulating tumor DNA early during treatment, measured by a simple and affordable assay that can be easily implemented in the clinic, can be used as a prognostic tool to identify these patients.
Youssra Salhi, Stavros Makrodimitris, Sandra van Wilpe, Iris te Paske, Vanja de Weerd, Corine M. Beaufort, Hans M. Westgeest, Jens Voortman, Maureen J. B. Aarts, Maud Rijnders, Astrid A. M. van der Veldt, Ronald de Wit, Niven Mehra, Saskia M. Wilting, Debbie G. J. Robbrecht   +14 more
wiley   +1 more source

Description of a Pharmacist-Led Mobile Health Clinic to Fill Primary Care Coverage in a Medically Underserved Rural Area. [PDF]

Int J Environ Res Public Health
Eddy E, Beatty S, Nau D, Kier KL, Musser M, Rush M.   +5 more
europepmc   +1 more source

MITF maintains genome stability in nonmelanocyte lineages

Molecular Oncology, EarlyView.
MITF is essential for melanocyte survival and acts as an oncogene in 10%–20% of melanomas. We show that MITF depletion causes genome instability in nonmelanocytic cells, leading to LATS2‐mediated P53 activation, cell cycle arrest, and apoptosis. This study highlights the role of MITF as a genome maintenance factor beyond the melanocyte lineage. Created
Drifa H. Gudmundsdottir, Adrián López García de Lomana, Thejus B. Venkatesh, Kritika Kirty, Snaevar Sigurdsson, Linda Vidarsdottir, Ramile Dilshat, Erla Sveinbjornsdottir, Snaedis Ragnarsdottir, Daniel H Magnusson, Maria R. Bustos, Eirikur Steingrimsson, Thorkell Gudjonsson, Stefan Sigurdsson   +13 more
wiley   +1 more source

Emerging advancements and expanding technological scope of education and practices in pharmacy and pharmaceutical sciences. [PDF]

Bioimpacts
Barar J, Fiano K, Seamon M, Albensi B, Khanfar N, Omidi Y.   +5 more
europepmc   +1 more source

Pharmacist prescribers.

Journal of primary health care, 2010
Wheeler, Amanda, Hale, Andrew, Jensen, Maree, Coombes, Ian, Stokes, Julie, Stowasser, Danielle, Nissen, Lisa   +6 more
openaire   +2 more sources

A novel quinazolinone insulin receptor inhibitor and its synergy with an EGFR inhibitor in glucose‐driven glioblastoma

Molecular Oncology, EarlyView.
The novel styrylquinazolinone‐based molecule W1B effectively suppresses glioblastoma by inhibiting IGF1R and EGFR. In high‐glucose microenvironments driving tumor resistance, W1B acts synergistically with the EGFR inhibitor dacomitinib. This combination safely blocks compensatory survival signaling in zebrafish xenograft models. Showcasing promising in
Patryk Rurka, Wioleta Cieślik, Wojciech Płaziński, Katarzyna Stępnik, Anna Boguszewska‐Czubara, Elżbieta Kot, Robert Musioł, Mateusz Jasica, Anna Mrozek‐Wilczkiewicz, Katarzyna Malarz   +9 more
wiley   +1 more source

Impact of a psychiatric pharmacist on an inpatient psychiatry consultation liaison service. [PDF]

Ment Health Clin
Ferro H, Dress J.
europepmc   +1 more source

Antibiotic prescribing by non-medical healthcare professionals in primary care: a systematic review of effects on antibiotic use, patient experience, interprofessional relationships and job satisfaction. [PDF]

JAC Antimicrob Resist
Veillard H, Lalani M, Mays N, Glover RE.
europepmc   +1 more source

Pharmacists Unite!

The Canadian Journal of Hospital Pharmacy, 2011
openaire   +3 more sources

The impact of hospital pharmacists' psychological contracts on medication adherence management: The mediating role of job burnout. [PDF]

PLoS One
Luo Y, Nie M, Chen C, He Y, Jiang X, Tang J, Zhang T, Gu Y, Tang F.   +8 more
europepmc   +1 more source